SlideShare a Scribd company logo
1 of 1
Download to read offline
FDA Regulation in Pharmacy Compounding - Risks and Critical
Issues to Consider
This webinar on FDA Pharmacy Compounding will detail the current thinking, the efforts made
and steps taken by FDA and legislatures since the “meningitis outbreak” in 2012.
Why Should You Attend:
Since the meningitis outbreak caused by contaminated compounded drugs, congressional
hearings ensued and Congress has sought to pass legislation. Did you know that there are
currently two versions of legislation in the works by the House of Representatives that attempt
to clarify FDA’s authority?
This webinar will review how the government may potentially regulate pharmacy
compounding. There are many questions surrounding the scope of what should be regulated should ever compounding pharmacy worry whether they will be compliant? This webinar
details FDA’s traditional approach to compounding and how it has regulated compounding to
date, FDA’s current thought process on why it does not believe it has authority to regulate and
its policy statement which states that violations related to activities viewed as “drug
manufacturing” may lead to FDA enforcement.
Areas Covered in the Webinar:
Overview of FDA regulation over FDA compounding
Issues regarding FDA Enforcement on New England Compounding Center
Current FDA compounding policy
Recent FDA Enforcement Trends
HR 3089
HR 3204
Who Will Benefit:
Compounding Pharmacists
Subcontractors of Compounding Pharmacies
Technicians
Chemists and Druggists
Pharma Regulatory affairs
Pharma QA/ QC

For more details visit us at:
http://www.complianceonline.com/ecommerce/control/trainingFocus/~produc
t_id=703164?channel=DOC_organic

More Related Content

What's hot

FDA Promotes Transparency, Collaboration for 2018
FDA Promotes Transparency, Collaboration for 2018FDA Promotes Transparency, Collaboration for 2018
FDA Promotes Transparency, Collaboration for 2018Georgia_Bull
 
Gene Therapy and FDA Regulations
Gene Therapy and FDA RegulationsGene Therapy and FDA Regulations
Gene Therapy and FDA RegulationsEMMAIntl
 
Cannabis Science & Policy Summit - Day 2 - Reuter
Cannabis Science & Policy Summit - Day 2 - ReuterCannabis Science & Policy Summit - Day 2 - Reuter
Cannabis Science & Policy Summit - Day 2 - ReuterCannabisSummit
 
Does Your CBD Product Measure Up?
Does Your CBD Product Measure Up?Does Your CBD Product Measure Up?
Does Your CBD Product Measure Up?EMMAIntl
 
Cannabis Science & Policy Summit - Day 1 - Sabet
Cannabis Science & Policy Summit - Day 1 - SabetCannabis Science & Policy Summit - Day 1 - Sabet
Cannabis Science & Policy Summit - Day 1 - SabetCannabisSummit
 
Cannabis Science & Policy Summit - Day 1 - Caulkins
Cannabis Science & Policy Summit - Day 1 - CaulkinsCannabis Science & Policy Summit - Day 1 - Caulkins
Cannabis Science & Policy Summit - Day 1 - CaulkinsCannabisSummit
 
Cannabis Science & Policy Summit - Day 2 - Novak
Cannabis Science & Policy Summit - Day 2 - NovakCannabis Science & Policy Summit - Day 2 - Novak
Cannabis Science & Policy Summit - Day 2 - NovakCannabisSummit
 
Cannabis Science & Policy Summit - Day 1 - Wetterau
Cannabis Science & Policy Summit - Day 1 - WetterauCannabis Science & Policy Summit - Day 1 - Wetterau
Cannabis Science & Policy Summit - Day 1 - WetterauCannabisSummit
 
How to respond to what healthcare professionals are telling us?
How to respond to what healthcare professionals are telling us?How to respond to what healthcare professionals are telling us?
How to respond to what healthcare professionals are telling us?Agnitio
 
Relevant Healthcare's Pharmacy Transparency Tool
Relevant Healthcare's Pharmacy Transparency ToolRelevant Healthcare's Pharmacy Transparency Tool
Relevant Healthcare's Pharmacy Transparency ToolScott Fuqua
 

What's hot (15)

FDA Promotes Transparency, Collaboration for 2018
FDA Promotes Transparency, Collaboration for 2018FDA Promotes Transparency, Collaboration for 2018
FDA Promotes Transparency, Collaboration for 2018
 
Gene Therapy and FDA Regulations
Gene Therapy and FDA RegulationsGene Therapy and FDA Regulations
Gene Therapy and FDA Regulations
 
Cannabis Science & Policy Summit - Day 2 - Reuter
Cannabis Science & Policy Summit - Day 2 - ReuterCannabis Science & Policy Summit - Day 2 - Reuter
Cannabis Science & Policy Summit - Day 2 - Reuter
 
Does Your CBD Product Measure Up?
Does Your CBD Product Measure Up?Does Your CBD Product Measure Up?
Does Your CBD Product Measure Up?
 
Pharma cost
Pharma costPharma cost
Pharma cost
 
Surya Singh: "From Development to Delivery in the US"
Surya Singh: "From Development to Delivery in the US"Surya Singh: "From Development to Delivery in the US"
Surya Singh: "From Development to Delivery in the US"
 
Cannabis Science & Policy Summit - Day 1 - Sabet
Cannabis Science & Policy Summit - Day 1 - SabetCannabis Science & Policy Summit - Day 1 - Sabet
Cannabis Science & Policy Summit - Day 1 - Sabet
 
Cannabis Science & Policy Summit - Day 1 - Caulkins
Cannabis Science & Policy Summit - Day 1 - CaulkinsCannabis Science & Policy Summit - Day 1 - Caulkins
Cannabis Science & Policy Summit - Day 1 - Caulkins
 
Cannabis Science & Policy Summit - Day 2 - Novak
Cannabis Science & Policy Summit - Day 2 - NovakCannabis Science & Policy Summit - Day 2 - Novak
Cannabis Science & Policy Summit - Day 2 - Novak
 
4x8 poster 07082016_2
4x8 poster 07082016_24x8 poster 07082016_2
4x8 poster 07082016_2
 
Netabolics pitch
Netabolics pitchNetabolics pitch
Netabolics pitch
 
Cannabis Science & Policy Summit - Day 1 - Wetterau
Cannabis Science & Policy Summit - Day 1 - WetterauCannabis Science & Policy Summit - Day 1 - Wetterau
Cannabis Science & Policy Summit - Day 1 - Wetterau
 
How to respond to what healthcare professionals are telling us?
How to respond to what healthcare professionals are telling us?How to respond to what healthcare professionals are telling us?
How to respond to what healthcare professionals are telling us?
 
3
33
3
 
Relevant Healthcare's Pharmacy Transparency Tool
Relevant Healthcare's Pharmacy Transparency ToolRelevant Healthcare's Pharmacy Transparency Tool
Relevant Healthcare's Pharmacy Transparency Tool
 

Similar to Fda regulation in pharmacy compounding

Drug Safety: Perspectives on Industry's Duties in the Post-Vioxx Age.
Drug Safety:  Perspectives on Industry's Duties in the Post-Vioxx Age.Drug Safety:  Perspectives on Industry's Duties in the Post-Vioxx Age.
Drug Safety: Perspectives on Industry's Duties in the Post-Vioxx Age.Michael Swit
 
What are “Cosmeceuticals”?
What are “Cosmeceuticals”?What are “Cosmeceuticals”?
What are “Cosmeceuticals”?EMMAIntl
 
Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsMichael Swit
 
Extreme Makeover
Extreme MakeoverExtreme Makeover
Extreme Makeoverrxmike
 
Background note for ad hoc group on med
Background note for ad hoc group on medBackground note for ad hoc group on med
Background note for ad hoc group on medJames Andrews
 
3 hr virtual seminar china compliance processes for life science products
3 hr virtual seminar china compliance processes for life science products3 hr virtual seminar china compliance processes for life science products
3 hr virtual seminar china compliance processes for life science productscomplianceonline123
 
Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsMichael Swit
 
What Is the Scope of Pharmaceutical Regulatory Affairs In The USA.docx
What Is the Scope of Pharmaceutical Regulatory Affairs In The USA.docxWhat Is the Scope of Pharmaceutical Regulatory Affairs In The USA.docx
What Is the Scope of Pharmaceutical Regulatory Affairs In The USA.docxDDReg Pharma
 
Drug Delivery -- Perspectives on the FDA Regulatory Environment
Drug Delivery -- Perspectives on the FDA Regulatory EnvironmentDrug Delivery -- Perspectives on the FDA Regulatory Environment
Drug Delivery -- Perspectives on the FDA Regulatory EnvironmentMichael Swit
 
Marketing to Medicare or Medicaid Beneficiaries - What You Can and Cannot Do ...
Marketing to Medicare or Medicaid Beneficiaries - What You Can and Cannot Do ...Marketing to Medicare or Medicaid Beneficiaries - What You Can and Cannot Do ...
Marketing to Medicare or Medicaid Beneficiaries - What You Can and Cannot Do ...Compliance Global Inc
 
Fda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science IndustryFda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science Industrydmanalan
 
Group4padgett&becoatm6a1
Group4padgett&becoatm6a1Group4padgett&becoatm6a1
Group4padgett&becoatm6a1Stephen Padgett
 
Group4 padgett&becoatm6a1
Group4 padgett&becoatm6a1Group4 padgett&becoatm6a1
Group4 padgett&becoatm6a1Henry Becoat
 
Overcoming Regulatory, Clinical and Quality Challenges in Developing Combinat...
Overcoming Regulatory, Clinical and Quality Challenges in Developing Combinat...Overcoming Regulatory, Clinical and Quality Challenges in Developing Combinat...
Overcoming Regulatory, Clinical and Quality Challenges in Developing Combinat...Michael Swit
 
FDA Drug Approval Regulations & Safety
FDA Drug Approval Regulations & SafetyFDA Drug Approval Regulations & Safety
FDA Drug Approval Regulations & SafetyDr Dev Kambhampati
 
Pharmaceutical companies and SEO search results compliance
Pharmaceutical companies and SEO search results compliancePharmaceutical companies and SEO search results compliance
Pharmaceutical companies and SEO search results complianceMarcos Richardson
 
FDA Enforcement – Trends, Powers and Penalties Or “Why Crime Does Not Pay”
FDA Enforcement – Trends, Powers and Penalties Or “Why Crime Does Not Pay”FDA Enforcement – Trends, Powers and Penalties Or “Why Crime Does Not Pay”
FDA Enforcement – Trends, Powers and Penalties Or “Why Crime Does Not Pay”Michael Swit
 

Similar to Fda regulation in pharmacy compounding (20)

Life Sciences Report
Life Sciences ReportLife Sciences Report
Life Sciences Report
 
FDA Enforcement
FDA EnforcementFDA Enforcement
FDA Enforcement
 
Drug Safety: Perspectives on Industry's Duties in the Post-Vioxx Age.
Drug Safety:  Perspectives on Industry's Duties in the Post-Vioxx Age.Drug Safety:  Perspectives on Industry's Duties in the Post-Vioxx Age.
Drug Safety: Perspectives on Industry's Duties in the Post-Vioxx Age.
 
What are “Cosmeceuticals”?
What are “Cosmeceuticals”?What are “Cosmeceuticals”?
What are “Cosmeceuticals”?
 
Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC Drugs
 
Extreme Makeover
Extreme MakeoverExtreme Makeover
Extreme Makeover
 
Background note for ad hoc group on med
Background note for ad hoc group on medBackground note for ad hoc group on med
Background note for ad hoc group on med
 
3 hr virtual seminar china compliance processes for life science products
3 hr virtual seminar china compliance processes for life science products3 hr virtual seminar china compliance processes for life science products
3 hr virtual seminar china compliance processes for life science products
 
Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC Drugs
 
What Is the Scope of Pharmaceutical Regulatory Affairs In The USA.docx
What Is the Scope of Pharmaceutical Regulatory Affairs In The USA.docxWhat Is the Scope of Pharmaceutical Regulatory Affairs In The USA.docx
What Is the Scope of Pharmaceutical Regulatory Affairs In The USA.docx
 
Drug Delivery -- Perspectives on the FDA Regulatory Environment
Drug Delivery -- Perspectives on the FDA Regulatory EnvironmentDrug Delivery -- Perspectives on the FDA Regulatory Environment
Drug Delivery -- Perspectives on the FDA Regulatory Environment
 
Trends in GMP Compliance: 2012
Trends in GMP Compliance: 2012Trends in GMP Compliance: 2012
Trends in GMP Compliance: 2012
 
Marketing to Medicare or Medicaid Beneficiaries - What You Can and Cannot Do ...
Marketing to Medicare or Medicaid Beneficiaries - What You Can and Cannot Do ...Marketing to Medicare or Medicaid Beneficiaries - What You Can and Cannot Do ...
Marketing to Medicare or Medicaid Beneficiaries - What You Can and Cannot Do ...
 
Fda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science IndustryFda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science Industry
 
Group4padgett&becoatm6a1
Group4padgett&becoatm6a1Group4padgett&becoatm6a1
Group4padgett&becoatm6a1
 
Group4 padgett&becoatm6a1
Group4 padgett&becoatm6a1Group4 padgett&becoatm6a1
Group4 padgett&becoatm6a1
 
Overcoming Regulatory, Clinical and Quality Challenges in Developing Combinat...
Overcoming Regulatory, Clinical and Quality Challenges in Developing Combinat...Overcoming Regulatory, Clinical and Quality Challenges in Developing Combinat...
Overcoming Regulatory, Clinical and Quality Challenges in Developing Combinat...
 
FDA Drug Approval Regulations & Safety
FDA Drug Approval Regulations & SafetyFDA Drug Approval Regulations & Safety
FDA Drug Approval Regulations & Safety
 
Pharmaceutical companies and SEO search results compliance
Pharmaceutical companies and SEO search results compliancePharmaceutical companies and SEO search results compliance
Pharmaceutical companies and SEO search results compliance
 
FDA Enforcement – Trends, Powers and Penalties Or “Why Crime Does Not Pay”
FDA Enforcement – Trends, Powers and Penalties Or “Why Crime Does Not Pay”FDA Enforcement – Trends, Powers and Penalties Or “Why Crime Does Not Pay”
FDA Enforcement – Trends, Powers and Penalties Or “Why Crime Does Not Pay”
 

More from complianceonline123

Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements  for otc drugsFda adverse event reporting requirements  for otc drugs
Fda adverse event reporting requirements for otc drugscomplianceonline123
 
Social media risks rules policies procedures
Social media risks rules policies  proceduresSocial media risks rules policies  procedures
Social media risks rules policies procedurescomplianceonline123
 
Excel spreadsheets how to ensure 21 cfr part 11 compliance
Excel spreadsheets  how to ensure 21 cfr part 11 complianceExcel spreadsheets  how to ensure 21 cfr part 11 compliance
Excel spreadsheets how to ensure 21 cfr part 11 compliancecomplianceonline123
 
Out in the open protecting your privacy in the digital age
Out in the open  protecting your privacy in the digital ageOut in the open  protecting your privacy in the digital age
Out in the open protecting your privacy in the digital agecomplianceonline123
 
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s PotentialReaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potentialcomplianceonline123
 
Audit Process: How to Successfully Plan Audit
Audit Process: How to Successfully Plan Audit Audit Process: How to Successfully Plan Audit
Audit Process: How to Successfully Plan Audit complianceonline123
 
Aml non bank finanacial institutions
Aml non bank finanacial institutionsAml non bank finanacial institutions
Aml non bank finanacial institutionscomplianceonline123
 
Gdp how to manage documentation lifecycle
Gdp  how to manage documentation lifecycleGdp  how to manage documentation lifecycle
Gdp how to manage documentation lifecyclecomplianceonline123
 

More from complianceonline123 (20)

Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements  for otc drugsFda adverse event reporting requirements  for otc drugs
Fda adverse event reporting requirements for otc drugs
 
Social media risks rules policies procedures
Social media risks rules policies  proceduresSocial media risks rules policies  procedures
Social media risks rules policies procedures
 
Fmla ada overlap
Fmla  ada  overlapFmla  ada  overlap
Fmla ada overlap
 
Hipaa enforcement examples
Hipaa enforcement examplesHipaa enforcement examples
Hipaa enforcement examples
 
Excel spreadsheets how to ensure 21 cfr part 11 compliance
Excel spreadsheets  how to ensure 21 cfr part 11 complianceExcel spreadsheets  how to ensure 21 cfr part 11 compliance
Excel spreadsheets how to ensure 21 cfr part 11 compliance
 
Retail loss
Retail lossRetail loss
Retail loss
 
Hipaa privacy rule
Hipaa privacy ruleHipaa privacy rule
Hipaa privacy rule
 
Fda warning letters
Fda  warning lettersFda  warning letters
Fda warning letters
 
Dietary supplement
Dietary supplementDietary supplement
Dietary supplement
 
Out in the open protecting your privacy in the digital age
Out in the open  protecting your privacy in the digital ageOut in the open  protecting your privacy in the digital age
Out in the open protecting your privacy in the digital age
 
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s PotentialReaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
 
Audit Process: How to Successfully Plan Audit
Audit Process: How to Successfully Plan Audit Audit Process: How to Successfully Plan Audit
Audit Process: How to Successfully Plan Audit
 
Basics of internal audit
Basics of internal auditBasics of internal audit
Basics of internal audit
 
Free trade zones
Free trade zonesFree trade zones
Free trade zones
 
Sec what you need to know
Sec what you need to knowSec what you need to know
Sec what you need to know
 
Auditing your grc programs
Auditing your grc programsAuditing your grc programs
Auditing your grc programs
 
Aml non bank finanacial institutions
Aml non bank finanacial institutionsAml non bank finanacial institutions
Aml non bank finanacial institutions
 
Gdp how to manage documentation lifecycle
Gdp  how to manage documentation lifecycleGdp  how to manage documentation lifecycle
Gdp how to manage documentation lifecycle
 
Workplace harrasment
Workplace harrasmentWorkplace harrasment
Workplace harrasment
 
Good documentation practices
Good documentation practicesGood documentation practices
Good documentation practices
 

Fda regulation in pharmacy compounding

  • 1. FDA Regulation in Pharmacy Compounding - Risks and Critical Issues to Consider This webinar on FDA Pharmacy Compounding will detail the current thinking, the efforts made and steps taken by FDA and legislatures since the “meningitis outbreak” in 2012. Why Should You Attend: Since the meningitis outbreak caused by contaminated compounded drugs, congressional hearings ensued and Congress has sought to pass legislation. Did you know that there are currently two versions of legislation in the works by the House of Representatives that attempt to clarify FDA’s authority? This webinar will review how the government may potentially regulate pharmacy compounding. There are many questions surrounding the scope of what should be regulated should ever compounding pharmacy worry whether they will be compliant? This webinar details FDA’s traditional approach to compounding and how it has regulated compounding to date, FDA’s current thought process on why it does not believe it has authority to regulate and its policy statement which states that violations related to activities viewed as “drug manufacturing” may lead to FDA enforcement. Areas Covered in the Webinar: Overview of FDA regulation over FDA compounding Issues regarding FDA Enforcement on New England Compounding Center Current FDA compounding policy Recent FDA Enforcement Trends HR 3089 HR 3204 Who Will Benefit: Compounding Pharmacists Subcontractors of Compounding Pharmacies Technicians Chemists and Druggists Pharma Regulatory affairs Pharma QA/ QC For more details visit us at: http://www.complianceonline.com/ecommerce/control/trainingFocus/~produc t_id=703164?channel=DOC_organic